Cubist Pharmaceuticals is Pharmaceuticals in United States that focus on care environments business. Founded in 1992. They cover business area such as researcher, developer, novel acute care therapy, use, hospital, Acute care, daptomycin, injection, anti-infective call lipopeptide, ENTEREGŪ, alvimopan, gastrointestinal recovery, partial large or small bowel resection surgery, primary anastomosis.
1992
( 32 years old in 2024 )
Care Environments
-
65 Hayden Avenue
Lexington, MA 02421
United States
Private
researcherdevelopernovel acute care therapyusehospitalAcute caredaptomycininjectionanti-infective call lipopeptideENTEREGŪalvimopangastrointestinal recoverypartial large or small bowel resection surgeryprimary anastomosis
* We use standard office opening hours in near Cubist Pharmaceuticals's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Cubist Pharmaceuticals is Pharmaceuticals business from United States that founded in 1992 (32 years old in 2024), Cubist Pharmaceuticals business is focusing on Care Environments.
Cubist Pharmaceuticals headquarter office and corporate office address is located in 65 Hayden Avenue Lexington, MA 02421 United States.
Cubist Pharmaceuticals was founded in United States.
In 2024, Cubist Pharmaceuticals is currently focus on care environments sector.
Above is snippet of Google Trends for "care environments" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Cubist Pharmaceuticals, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
